Poster Consideration Deadline:

Friday, March 5, 2021

Research Funding Deadline extended to 1/31/21

The American Society of Clinical Oncology (ASCO) Survey on COVID-19 in Oncology Registry (ASCO Registry) aims to help the cancer community learn more about the patterns of symptoms and severity of COVID-19 among patients with cancer, as well as, how COVID-19 is impacting the delivery of cancer care and patient outcomes.

ASCO will deliver periodic reports with key findings so that the oncology community has real-time information to help inform treatment approaches for patients with cancer who have a confirmed COVID-19 infection. The reports will allow practices to easily and confidentially share information on COVID-19 infections among their patients.

More Details

ASCO Registry FAQs

Enroll Your Practice

• Enhertu Advanced Gastric Broadcast  March 4th 

• Clinical Management of 1L Advanced RCC Patients on CABOMETYX® + OPDIVO® March 4th

• Epizyme Educational Program (Virtual Webcast) on relapsed or refractory (R/R) follicular lymphoma (FL), March 17th

• CABOMETYX® + OPDIVO® : A New Combination Treatment for 1L Patients With Advanced Renal Cell Carcinoma March 18th
  

• Expanded Access Navigator
• Test4TRK™: NTRK Sponsored Testing Program

Latest FDA Approvals

Package/Label Updates

Other Updates

Do you have an idea, suggestion, or other feedback you'd like to share? Comment, concern or compliment? Us the button above to reach out and "Share with NNECOS."

We'd love to hear from you! 

• Advanced Practice Registered Nurse – Hematology/Oncology (Keene, NH)
• Medical Oncologist/Hematologist (Northern New York)
• Multiple Positions - New England Cancer Specialists Maine & New Hampshire

https://www.asco.org/asco-coronavirus-information